Valiant Organics Reports 22% Revenue Growth and Significant Profit Surge in Q1
Valiant Organics posted consolidated revenue of Rs 205.48 crore, up 22% year-over-year. Net profit surged to Rs 8.20 crore from Rs 0.62 crore. EBITDA rose 53% to Rs 19.75 crore, with margin improving to 9.60%. EPS increased to Rs 2.93 from Rs 0.23. Management projects 15-20% revenue growth for the full year with EBITDA margins of 10-12%. The company plans capital expenditure of Rs 100-120 crore for capacity expansion and new product development.
19Jun 25
Valiant Organics to Explore Fundraising Options in Upcoming Board Meeting
Valiant Organics Limited, a key player in the chemical industry, has announced a board meeting scheduled for June 25 to discuss and consider various fundraising options. This move could potentially impact the company's future growth strategies and financial structure. The specific details of the fundraising options have not been disclosed, but the decision could influence the company's stock performance and long-term prospects.
12Jun 25
Valiant Organics Withdraws ₹500 Million Rights Issue Citing Regulatory Changes
Valiant Organics Limited has withdrawn its proposed ₹500 million rights issue, citing unspecified regulatory changes as the reason. The decision impacts the company's capital raising strategy and maintains its current capital structure. The move reflects the company's cautious approach to compliance with evolving financial regulations in India. Shareholders and investors are advised to watch for alternative capital raising plans or strategic moves from the company.